Abstract:Purpose: β cell mass (BCM) and function are essential to the diagnosis and therapy of diabetes. Diabetic patients serve β cell loss is, and damage of β cells leads to severe insulin deficiency. Our understanding of the role of BCM in diabetes progression is extremely limited by lacking efficient methods to evaluate BCM in vivo. In vitro methods of labeling islets, including loading of contrast reagent or integration of exogenous biomarker, require artificial manipulation on islets, of which the clinical application is limited. Imaging methods targeting endogenous biomarkers may solve the above problems. However, traditional reagents targeting GLP-1R and VAMT2 result in a high background of adjacent tissues, complicating the identification of pancreatic signals. Here, we report a non-invasive and quantitative imaging technique by using radiolabeled glycine mimics ([18F]FBG, a boron-trifluoride derivative of glycine) to assay islet function and monitor BCM changes in living animals. Methods: Glycine derivatives, FBG, FBSa, 2Me-FBG, 3Me-FBG, were successfully synthesized and labeled with 18F. Specificity of glycine derivatives were characterized by in vitro experiment. PET imaging and biodistribution studies were performed in animal models carring GLYT over-expressed cells. In vivo evaluation of BCM with [18F]FBG were performed in STZ (streptozocin) induced T1D (type 1 diabetes) models. Results: GLYT responds to excess blood glycine levels and transports glycine into islet cells to maintain the activity of the glycine receptor (GLYR). Best PET imaging condition was 80 min after given a total of 240 ~ 250 nmol imaging reagent (a mixture of [18F]FBG and natural glycine) intravenously. [18F]FBG can detect both endogenous and exogenous islets clearly in vivo. When applied to STZ induced T1D mouse models, total uptake of [18F]FBG in the pancreas exhibited a linear correlation with survival BCM. Conclusion: [18F]FBG targeting the endogenous glycine transporter (GLYT), which is highly expressed on islet cells, avoiding extra modification on islet cells. Meanwhile the highly restricted expression pattern of GLYT excluded the background in adjacent tissues. This [18F]FBG-based imaging technique provides a non-invasive method to quantify BCM in vivo, implying a new evaluation index for diabetic assessment.

Using Endogenous Glycogen As Relaxation Agent for Imaging Liver Metabolism by MRI

MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST)

MRI of GlycoNOE in the human liver using GraspNOE‐Dixon

Simultaneous monitoring of glycogen, creatine, and phosphocreatine in type II glycogen storage disease using saturation transfer MRI

In vivo characterization of glycogen storage disease type III in a mouse model using glycoNOE MRI

Toward structure and metabolism of glycogen C1‐C6 in humans at 7 T by localized 13C MRS using low‐power bilevel broadband 1H decoupling

Oxygen and Glucose as Stimulation Agents for BOLD Functional MR Imaging of Rabbit Liver: A Feasibility Study.

B-Glycine as a marker for β cell imaging and β cell mass evaluation

Synthesis of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles with High Relaxivity for T1/T2 Dual-Contrast Magnetic Resonance Imaging

Sensitivity schemes for dynamic glucose-enhanced magnetic resonance imaging to detect glucose uptake and clearance in mouse brain at 3 T

Gadoxetic Disodium-Enhanced MRI to Characterize T1 Relaxation Values and Expression Level of Organic Anion Transporters and Multidrug Resistance Protein on Hepatocyte Surface Membrane of Normal C57BL/6 Mice

Biocompatible Caramelized Carbonaceous Nanospheres Supported Paramagnetic Ultrathin Manganese Oxide Nanosheets Via Self-Sacrificing Reduction As a MRI Contrast Agent for Liver Imaging

Towards Robust Glucose Chemical Exchange Saturation Transfer Imaging in Humans at 3 T: Arterial Input Function Measurements and the Effects of Infusion Time

In vivo detection of brain glycine with echo-time-averaged (1)H magnetic resonance spectroscopy at 4.0 T

PEGylation of Protein-Based MRI Contrast Agents Improves Relaxivities and Biocompatibilities.

Molecularly Targeted Magnetic Resonance Imaging and Spectroscopy

Measurement of Liver T1 and T2 Relaxation Times in an Experimental Mouse Model of Liver Fibrosis

Fast and Quantitative T1ρ-weighted Dynamic Glucose Enhanced MRI

Simultaneous dynamic glucose-enhanced (DGE) MRI and fiber photometry measurements of glucose in the healthy mouse brain

PET/MRI enables simultaneous in vivo quantification of β-cell mass and function

Research Progress of Glycogen Detection Methods